1-3 of 3
Junko Homan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Inhibition of the STAT3 and Src Pathways by NS-018, a JAK2 and Src-Family Kinase Inhibitor, Reduces Myeloma Cell Proliferation and Adhesion and Suppresses Osteoclast Formation

Kazuya Kuramoto, PhD, Ayumi Kodama, Junko Homan, Yohei Nakaya, Toshio Kitamura, MD, PhD, Haruna Naito, PhD
Journal: Blood
Blood (2011) 118 (21): 2900.
https://doi.org/10.1182/blood.V118.21.2900.2900
Published: 2011
Journal Articles

NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant

Kotaro Shide, Yohei Nakaya, Takuro Kameda, Haruko Shimoda, Tomonori Hidaka, Yoko Kubuki, Keiko Katayose, Takuya Matsunaga, Junko Homan, Takashi Kotera, Hiroshi Shibayama, Haruna Naito, Kazuya Shimoda
Journal: Blood
Blood (2010) 116 (21): 4106.
https://doi.org/10.1182/blood.V116.21.4106.4106
Published: 2010
Journal Articles

Preferential Inhibition of An Activated Form of Janus Kinase 2 (JAK2) by a Novel JAK2 Inhibitor, NS-018

Yohei Nakaya, Haruna Naito, Junko Homan, Seishi Sugahara, Tatsuya Horio, Tomoko Niwa, Kotaro Shide, Kazuya Shimoda
Journal: Blood
Blood (2010) 116 (21): 4107.
https://doi.org/10.1182/blood.V116.21.4107.4107
Published: 2010